| Trial ID: | L0988 |
| Source ID: | NCT00062764
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Long-Term Treatment of Nonalcoholic Steatohepatitis With Pioglitazone
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
Has Results
|
| Results: |
https://clinicaltrials.gov/ct2/show/results/NCT00062764
|
| Conditions: |
Hepatitis;Hepatitis;Hepatitis;Hepatitis
|
| Interventions: |
Drug: Actos (Pioglitazone);Drug: Actos (Pioglitazone);Drug: Actos (Pioglitazone);Drug: Actos (Pioglitazone)
|
| Outcome Measures: |
Number of Patients With Improvement in Liver Histology;Number of Patients With Improvement in Liver HistologyNumber of Patients With Impaired Glucose Tolerance After Treatment;Mean Increase of Insulin Sensitivity Index;Average Increase in Weight After Treatment;Mean BMI Change
|
| Sponsor/Collaborators: |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
All
|
| Age: |
18 Yearsnan
|
| Phases: |
Phase 2
|
| Enrollment: |
18
|
| Study Type: |
Interventional
|
| Study Designs: |
--
|
| Start Date: |
12/06/2003
|
| Completion Date: |
--
|
| Results First Posted: |
05/04/2011
|
| Last Update Posted: |
19 October 2017
|
| Locations: |
United States;United States;United States;United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00062764
|
